RNA, U6 small nuclear 1264, pseudogene (RNU6-1264P)

RNA, U6 small nuclear 1264, pseudogene (RNU6-1264P) is classified as a **pseudogene** in humans and is annotated as a noncoding RNA segment similar in sequence to U6 small nuclear RNAs, which are components of the spliceosome[1][3][5][9]. Pseudogenes like RNU6-1264P do **not encode functional proteins** and typically arise by gene duplication or retrotransposition events that generate incomplete, disabled, or silenced copies of otherwise active genes[6]. There is no evidence for RNU6-1264P being involved in pathogenic processes or being directly targeted by any drugs or therapies. Its genomic location is 17p13.2 (chromosome 17: 6,207,163-6,207,269)[1][3][5]. Although pseudogene transcripts can sometimes have regulatory impacts or be transcribed in certain tissues, there are no reports of such functions or disease associations for RNU6-1264P specifically. This entity is not a **therapeutic target, biomarker, or receptor**, and current knowledge supports its classification as a largely nonfunctional genomic element.

Other names

RNU6-1264PRNA, U6 snRNA 1264 pseudogene

None (no mechanism of drug action, as not therapeutically targeted)